What HC Solutions does

HC Solutions (legally Baltic HC Solutions OÜ) is an Estonian healthcare consultancy founded in 2012 that helps pharmaceutical, biotech, and medical device companies secure market access and reimbursement across European markets. The firm operates from Viimsi Parish, Harju County, Estonia, with a multidisciplinary team of roughly 16 personnel — including medical professionals, IT specialists, bioresearchers, biostatisticians, and cost-effectiveness analysts, supplemented by external experts in biostatistics, mathematics, and data science.

The company's service portfolio spans five integrated lines: Market Access and HTA Consulting (HTA dossier preparation, reimbursement strategy, budget impact modelling, business opportunity assessment); Medical Writing and Literature Search (regulatory writing, systematic reviews, meta-analyses); Predictive Modelling in Healthcare (patient-based cost-efficiency modelling, economic impact analyses, value-based healthcare assessment, personalised medicine including AI-driven risk prediction and genomics/biomarker analysis); Medical Device / SaMD services (HTA, pricing, early evidence planning); and Regulatory Affairs and Pharmacovigilance (regulatory submissions, MRP/DCP procedures, labelling, Local Responsible Person for Pharmacovigilance). A proprietary asset is the first pan-European healthcare model developed in 2020, and 2024 research extends predictive modelling into macroeconomic healthcare impact assessment.

HC Solutions generates revenue through project-based consulting engagements and multi-year contracts with enterprise pharmaceutical, biotech, and medical device clients, as well as medical device startups. Pricing is custom-quoted with no public rate card, and go-to-market is consultative B2B sales delivered via direct engagement, the company website, and industry events — with no reseller or partner channel. The company claims 100+ successful reimbursement projects delivered since 2012, and serves clients globally with a European concentration, led by the Baltic region.

Name

HC Solutions

Legal name

Baltic HC Solutions OÜ

Website

https://hcsolutions.ee

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

HC Solutions is an Estonian healthcare consultancy founded in 2012 that provides market access, HTA, predictive modelling, medical writing, medical device, and regulatory affairs services to pharmaceutical, biotech, and medical device companies across European markets.

Ownership category

akta.pro rank

Product category

Healthcare Market Access Consulting

NAICS

Management Consulting Services (54161)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)

akta.pro primary industry

Health Technology Assessment (HTA) & Reimbursement Policy Bodies (HLAJACAF)

akta.pro secondary industry

Cost of Care, Spend Analytics & Financial Performance Management (HLACAHAJ)

Keywords

• Healthcare market access
• HTA consulting services
• Predictive healthcare modelling
• Medical device reimbursement
• Regulatory affairs consulting

Headquarters

HQ city

Harju

HQ country

Estonia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Healthcare Consultancy Services: B2B consulting services for pharmaceutical and medical device companies including market access strategy, HTA consulting, regulatory affairs, pharmacovigilance, medical writing, and predictive modelling. Revenue generated through project-based engagements and ongoing consulting retainer arrangements.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

HC Solutions is a healthcare consultancy delivering market access services, Health Technology Assessment (HTA) consulting, predictive modelling, medical writing, medical device reimbursement support, and regulatory affairs and pharmacovigilance services for pharmaceutical, biotech, and medical device companies across Europe. The firm helps healthcare innovators prepare HTA dossiers, develop reimbursement strategies, demonstrate cost-effectiveness through patient-based modelling, and navigate regulatory pathways in the Baltic region and broader European markets.

Product overview

HC Solutions is a healthcare consultancy company offering a unified portfolio of consulting services rather than a software product platform. The core offering centers on Market Access Services (including HTA consulting, reimbursement strategy, and dossier preparation) and Predictive Modelling in Healthcare (patient-based cost-efficiency modelling, economic impact analyses, and personalized medicine). Supporting these are specialized services including Medical Writing and Literature Search Services (regulatory writing, systematic reviews, meta-analyses), Medical Device/Software as Medical Device Services (HTA strategy, pricing, early evidence planning), and Regulatory Affairs and Pharmacovigilance (regulatory submissions, MRP/DCP assistance, labelling, pharmacovigilance). The services are delivered by a multidisciplinary team and are designed to work together holistically—e.g., predictive modelling supports the market access and pricing strategies, while regulatory affairs and medical writing provide evidence to underpin HTA dossiers.

Differentiator

Problem solved

Functional benefit

Products and services

• Market Access and HTA Consulting Services Comprehensive consulting to help bring healthcare innovations to market, including crafting robust HTA dossiers, shaping long-term reimbursement strategies, cost-effectiveness analyses, budget impact modelling, business opportunity assessment, sustainable pricing strategies, and patient access schemes for pharmaceutical, biotech, and medical device clients.
• Medical Writing and Literature Search Services Delivery of precise, well-structured medical content including regulatory writing, scientific publications, medical communications, systematic literature reviews, targeted literature searches, critical appraisal, meta-analyses, comparative effectiveness research, and real-world data analysis for healthcare professionals and regulatory submissions.
• Predictive Modelling in Healthcare Data-driven predictive tools for healthcare decisions including patient-based cost-efficiency modelling, economic impact analyses (healthcare policy change, pandemic and public health crisis modelling, workforce productivity and GDP growth analysis), value-based healthcare assessment, personalized medicine analytics (genomics, biomarker analysis, AI-driven risk prediction), and employer workforce health studies.
• Medical Device / Software as Medical Device Services Support for medical device innovators with HTA and reimbursement strategies, cost modelling, pricing negotiations, early evidence planning for investigational studies, regulatory alignment, and crafting reimbursement roadmaps to secure funding and market approvals for both established medical device companies and startups.
• Regulatory Affairs and Pharmacovigilance Strategic and operational regulatory support across the Baltic region including pharmaceutical regulatory submissions, MRP/DCP (Mutual Recognition and Decentralised Procedures) assistance and local liaison, end-to-end Marketing Authorisation Application management, labelling and product information management (translations, packaging maintenance), and pharmacovigilance services including Local Responsible Person for Pharmacovigilance (LPPV), safety data collection, EU QPPV reporting, and local literature screening.

Quantifiable outcome

• 100+ successful reimbursement projects delivered since 2012
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Cogentia Healthcare Consulting: Cogentia is a UK/European health economics and market access consultancy. Comparable boutique competitor delivering HTA submissions, health economic modelling, and pricing strategy to pharma and medical device companies.
• Evidera: Evidera (now part of Thermo Fisher/PPD) is a leading HEOR, market access, and HTA consulting firm serving pharma and biotech. Direct comparable — both deliver HTA dossier preparation, cost-effectiveness modelling, and value communication for the same pharmaceutical and medical device buyer base.
• Analytica LASER: Analytica LASER is a Canadian/European HEOR and market access consultancy providing HTA submissions, cost-effectiveness modelling, and real-world evidence generation. Direct comparable for HC Solutions' predictive modelling and HTA service lines.
• Mtech Access: UK-based market access and HTA consultancy serving pharma and medical device clients across Europe. Comparable boutique peer with similar service portfolio including HTA submissions, systematic reviews, and payer engagement — competing for similar European mid-size pharma/medtech engagements.
• Xcenda: Xcenda (part of Cencora/AmerisourceBergen) provides HEOR, market access, and HTA consulting to pharma and medtech manufacturers. Direct comparable in payer evidence generation, HTA dossiers, and value-based contracting support.
• PHMR (Portland Health and Marketing Research): PHMR is a specialist market access and HEOR consultancy working with pharma, biotech, and medical device companies. Direct competitor in HTA dossier preparation, value demonstration, and pricing/reimbursement strategy across European markets.

Broad incumbents

• Parexel International: Parexel is a major global CRO with a market access and HEOR practice. Competes with HC Solutions on HTA submissions and pricing strategy for pharma clients, but operates at a much larger scale with broader clinical and regulatory services.
• Syneos Health: Syneos Health is a global biopharma solutions organization offering market access, HEOR, and HTA consulting alongside clinical and commercial services. Broader incumbent competing with HC Solutions for integrated pharma engagement opportunities.
• Charles River Associates (Life Sciences Practice): CRA's Life Sciences practice provides HEOR, market access, and pricing strategy consulting to pharma and medical device clients. Established competitor in the same HTA/value demonstration space, though typically serves larger enterprise engagements.
• IQVIA: IQVIA is a global CRO and health data giant offering integrated market access, HEOR, and HTA consulting as part of broader clinical and commercial services. Competes with HC Solutions for pharma market access engagements but offers much wider portfolio including RWE, clinical, and commercial.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/baltic-hc-solutions

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HC Solutions